Mark C. Throdahl is Director at ORTHOPEDIATRICS CORP (KIDS). They have made 12 open-market trades across 1 company since 2018, most recently 2026-06-09.
CIK 0001439415
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KIDS | SELL | 2024-03-11 | 2024-03-12 | $27.59 | $134K | -5.3% | +16.0% | +9.5% |
| KIDS | SELL | 2023-03-06 | 2023-03-07 | $43.83 | $396K | -1.1% | +9.2% | +2.5% |
| KIDS | SELL | 2022-03-02 | 2022-03-03 | $58.60 | $699K | -13.1% | +5.8% | -15.7% |
| KIDS | SELL | 2021-08-03 | 2021-08-04 | $65.40 | $624K | -0.1% | +11.8% | +10.6% |
| KIDS | SELL | 2021-08-02 | 2021-08-03 | $65.88 | $2.0M | -2.5% | +9.0% | +8.3% |
| KIDS | SELL | 2021-03-01 | 2021-03-03 | $55.88 | $570K | -13.5% | -4.5% | +15.9% |
| KIDS | SELL | 2021-02-05 | 2021-02-09 | $50.34 | $1.3M | +8.7% | -13.4% | +12.2% |
| KIDS | SELL | 2021-02-04 | 2021-02-05 | $50.18 | $738K | +7.5% | -7.2% | +21.9% |
| KIDS | SELL | 2020-06-25 | 2020-06-29 | $42.88 | $1.1M | -2.4% | -1.6% | +3.3% |
| KIDS | SELL | 2020-05-20 | 2020-05-21 | $46.56 | $69K | +0.7% | -2.7% | +19.4% |
| KIDS | SELL | 2019-12-13 | 2019-12-13 | $34.31 | $343K | +3.0% | +5.4% | -23.2% |
| KIDS | SELL | 2018-04-13 | 2018-04-16 | $17.92 | $987K | +0.7% | +0.3% | +52.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.